From: A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers
Gene | Cell lines | T-ALL (%) | B-ALL (%) | PB/BM controls | Expression upregulation after 5azaDC |
---|---|---|---|---|---|
ARHGAP20 | 6/10 | 4/12 (33) | 33/51 (65) | 0/8 | YES |
ATG16L2 | 3/7 | 5/12 (42) | 14/52 (27) | 0/8 | ND |
BARHL2† | 5/6 | 3/12 (25) | 39/51 (77) | 0/9 | YES |
BMP2† | 6/7 | 7/12 (58) | 2/52 (4) | 0/8 | YES |
CDC14B | 5/7 | 4/12 (33) | 21/48 (44) | 0/9 | YES |
CYP1B1† | 5/6 | 5/12 (42) | 40/52 (77) | 0/10 | YES |
DUSP4 | 1/6 | 3/12 (25) | 13/52 (25) | 0/6 | ND |
EBF2 | 5/6 | 10/12 (83) | 49/52 (94) | 1/10 | YES |
EYA2 | 5/7 | 3/12 (25) | 15/47 (32) | 0/10 | YES |
FAT1† | 1/6 | 3/12 (25) | 34/52 (65) | 0/10 | YES |
FOXF2 | 4/6 | 3/12 (25) | 15/52 (29) | 0/9 | YES |
GPR123 | 5/7 | 4/12 (33) | 10/48 (21) | 0/9 | YES |
HLA-F | 4/6 | 4/12 (33) | 7/52 (14) | 1/10 | ND |
KNDC1 | 4/7 | 1/12 (8) | 9/40 (23) | 0/9 | YES |
MYO10† | 6/8 | 6/12 (50) | 8/51 (16) | 1/8 | YES |
NKX2-1 | 5/6 | 5/12 (42) | 32/51 (63) | 0/9 | YES |
N2RE1 | 6/6 | 4/12 (33) | 19/49 (39) | 0/8 | YES |
NR4A2† | 3/7 | 6/12 (50) | 5/51 (10) | 0/9 | ND |
PAX2 | 6/7 | 2/10 (20) | 15/34 (44) | 0/9 | YES |
PAX6 | 3/6 | 6/12 (50) | 35/52 (67) | 0/10 | YES |
POU4F1 | 1/6 | 5/12 (42) | 22/51 (43) | 0/8 | YES |
PRDM12 | 6/6 | 6/12 (50) | 30/45 (67) | 0/9 | YES |
PTGS2† | 4/6 | 6/12 (50) | 48/52 (92) | 0/10 | YES |
SALL3 | 5/6 | 4/12 (33) | 25/52 (48) | 0/9 | YES |
SSPN | 7/9 | 4/12 (33) | 32/52 (62) | 0/8 | YES |
TCF2† | 5/6 | 6/12 (50) | 5/52 (10) | 0/10 | YES |
TFAP2A | 5/6 | 5/11 (46) | 33/49 (67) | 0/10 | YES |
TFAP2C | 2/6 | 10/12 (83) | 43/50 (86) | 0/10 | YES |
TP53I11 | 3/6 | 3/12 (25) | 8/52 (15) | 0/9 | ND |
TRPC4 | 5/5 | 9/12 (75) | 48/52 (92) | 0/10 | YES |
TSHZ3† | 4/6 | 0/12 (0) | 16/52 (31) | 0/10 | ND |
UBE2C | 3/6 | 2/12 (17) | 12/52 (23) | 0/10 | YES |